FRIEDMAN, M.; Chemistry, Nutrition and Health-promoting Properties of Hericium erinaceus (Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds, Journal of Agricultural and Food Chemistry, (2015).
HUI, W. K., Effect of Culinary-Medicinal Lion’s Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) on Ethanol-Induced Gastric Ulcers in Rats, International Journal of Medicinal Mushrooms, 10(4), pp. 325 – 330, (2008).
KHAN, Md. Asaduzzama, et al.; Hericium erinaceus: an edible mushroom with medicinal values, J. Complement. Integr. Med., 10(1), pp. 1 – 6, (2013).
KAWAGISHI, H. et al.; Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum, Tetrahedron Letters, Vol. 35, nº. 10, pp. 1569 – 1572, (1994).
LAKSHMANAN, H. et al.; Haematological, biochemical and histopathological aspects of Hericium erinaceus ingestion in a rodent model: a sub-chronic toxicological assessment, Journal of Ethnopharmacology, (2016).
LEE, E. W. et al.; Two Novel Diterpenoids, Erinacines H and I from the Mycelia of Hericium erinaceum, Bioscience, Biotechnology, and Biochemistry, 64:11, pp. 2402 – 2405, (2000).
LI, I.-C. et al.; Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague–Dawley rats. Food Chem. Toxicol. (2014).
LIANG, B. et al.; Antihyperglycemic and Antihyperlipidemic Activities of Aqueous extract of Hericium erinaceus in experimental diabetic rats, BMC Complementary & Alternative Medicine. 13:253, (2013).
MA, B. J. et al.; Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus, Mycology, 1:2, pp. 92 – 98, (2010).
MORI, K. et al.; Improving Effects of the Mushroom Yamabushitake (Hericium erinaceus) on Mild Cognitive Impairment: A Double-blind Placebo-controlled Clinical Trial, Phytother. Res. 23, pp. 367 – 372, (2009).
MORI, K. et al.; Effects of Hericium erinaceus on amyloid β(25-35) peptide-induced learning and memory deficits in mice, Biomedical Research, 32 (1), pp.67 – 72, (2011).
NAGANO, M., et al.; Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake, Biomedical Research, 31(4), pp. 231-237, (2010).
PHAN, C. W. et al.; Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism, Critical Reviews in Biotechnology, 35(3), pp. 355-368, (2015).
SCHLIEBS, R., ARENDT T.; The cholinergic system in aging and neuronal degeneration, Behavioural Brain Research, 221, pp. 555–563 ,(2011).
SHAW, S. R. et al.; Dose translation from animal to human studies Revisited, The FASEB Journal, Vol.22, No.3, pp. 659-661, Dezembro, (2007).
WANG, J. C. et al.; Hypoglycemic effect of extract of Hericium erinaceus, Journal of the Science of Food and Agriculture, 85, p. 641 – 646, (2005).
WONG, K. H. et al.; Neuroregenerative Potential of Lion's Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Higher Basidiomycetes), in the Treatment of Peripheral Nerve Injury (Review), International Journal of Medicinal Mushrooms, 14(5), pp. 427– 446,
(2012).
WONG, J. Y. et al.; Gastroprotective Effects of Lion’s Mane Mushroom Hericium erinaceus (Bull.:Fr.) Pers. (Aphyllophoromycetideae) Extract against Ethanol-Induced Ulcer in Rats, Evidence-Based Complementary and Alternative Medicine Vol. 2013, (2013).
YANG, B. K. et al.; Hypolipidemic Effect of an Exo-biopolymer Produced from a Submerged Mycelial Culture of Hericium erinaceus, Bioscience, Biotechnology, and Biochemistry, 67:6. pp. 1292 – 1298, (2003).